AWK vs CRSP · P/E 22, rev $4.65B vs rev $37.3M
American Water Works (AWK) versus Crispr Therapeutics AG (CRSP) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported CRSP revenue for 2024-12-31 was $37.3M. Net income was -$366.3M. Revenue was down 89.9% from 2023-12-31 to 2024-12-31. CRSP currently screens at market cap $5.42B.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. CRSP currently screens at market cap $5.42B.
Not investment advice. Open the AWK and CRSP stock pages for the full models.
Not investment advice.